This trial will be testing a new drug called Alogabat that is meant to help 5-17 year olds with Angelman Syndrome.
Thank you for your interest, but this study is not currently enrolling.
United States (Nationwide)
Jamie Capal
Carolina Institute for Developmental Disabilities
Clinical or Medical
Interventional
Behavior
Child and Teen Health
Developmental
Genetics and Genetic Disorders
Parents of Children
Rare Diseases
23-0680
Copyright © 2013-2022 The NC TraCS Institute, the integrated home of the NIH Clinical and Translational Science Awards (CTSA) Program at UNC-CH. This website is made possible by CTSA Grant UL1TR002489 and the National Center for Advancing Translational Sciences.
Questions?
